Biblio
hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia. Cell Rep Med. 2022;3(8):100717.
Chronic myeloid leukemia: reminiscences and dreams. Haematologica. 2016;101(5):541-558.
.